Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04985604 |
| Consolidated Lead Sponsor | Day One Biopharmaceuticals |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 23 participants (ACTUAL) |
| Registered Start Date | 2021-07-15 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora, CO | Open Hospital Dossier -> |
| Oregon Health and Science University Knight Cancer Institute | Portland, OR | Open Hospital Dossier -> |
| UPMC Hillman Cancer Center | Pittsburgh, PA | Open Hospital Dossier -> |
| Vanderbilt University Medical Center | Nashville, TN | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.